MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » HealthQuest Capital looks to investments with its new $110M funding round | Medtech funding for the week of August 18, 2014

HealthQuest Capital looks to investments with its new $110M funding round | Medtech funding for the week of August 18, 2014

By

HealthQuest Capital raises $110M for healthcare investments

August 19, 2014 by Arezu Sarvestani

HealthQuest Capital raises $110M for healthcare investments

HealthQuest Capital is looking to make some moves healthcare with its newly raised $110 million fund, looking for unmet needs in medical devices, diagnostics and information technology.

The Sofinnova Ventures-backed investment group garnered a lot of support for its inaugural fund, which was only expected to raise about $50 million. HealthQuest didn’t release the names of its backers, but said that the funds came from “endowments, pensions and family offices,” among others. Read more

ElectroCore seeks commercial partners for non-invasive headache tech

August 18, 2014 by Brad Perriello

ElectroCore seeks commercial partners for non-invasive headache tech

ElectroCore said it tapped investment bank Piper Jaffray to help it court potential partners to commercialize the non-invasive vagus nerve stimulation treatment for headaches it’s developing.

The self-administered nVNS procedure is designed to treat migraine and cluster headaches, according to a press release; U.S. approval is expected in 2015, the company said. ElectroCore said it’s also working on trials for respiratory and gastric motility disorders, depression and anxiety. Read more

Seventh Sense lands $16M for non-invasive blood collection

August 13, 2014 by Arezu Sarvestani

Seventh Sense lands $16M for blood collection tech

Massachusetts-based Seventh Sense Biosystems added 3 new investors this month with the closing of its Series B financing round, which brought in $16 million for the the company’s blood sampling devices.

Siemens, Novartis and Laboratory Corp. of America became new funders in this round, joining existing backers Flagship Ventures and Polaris Partners, 7SBio announced. Read more

PCORI dangles $90M in grants for comparative effectiveness research

August 18, 2014 by Arezu Sarvestani

PCORI dangles $90M in grants for comparative effectivness research

The Patient-Centered Outcomes Research Institute is looking to dole out $90 million in support for clinical research, the organization announced today.

PCORI is looking for studies that will highlight practical questions in healthcare in order to help patients, doctors and other healthcare stakeholders make more informed decisions. Called “comparative effectiveness research,” the studies aim to compare drugs, surgery, devices and other medical options based on their relative benefits and risks. Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • 3M Health Care Business president is leaving this year
    3M Health Care Business Group President Mojdeh Poul will retire from the company on July 1, 2022. Poul joined Maple Grove, Minnesota-based 3M (NYSE:MMM) in 2011 as the global business VP of critical and chronic care solutions. She later became VP and general manager of the company’s food safety business and president of numerous 3M… […]
  • Iterative Scopes announces positive data in Skout AI colonoscopy algorithm clinical trial
    Iterative Scopes this week announced positive trial data in a study of its colorectal cancer screening algorithm, Skout. Cambridge, Massachusetts-based Iterative Scopes designed Skout as a computer-aided device (CADe) that uses artificial intelligence and computer vision technology to detect suspicious tissue and provide real-time feedback for gastroenterologists performing the procedure. Get the full story on… […]
  • Device developer SeaStar Medical hires chief medical officer
    SeaStar Medical has hired Dr. Kevin Chung as chief medical officer of the medtech developer starting July 1. Denver-based SeaStar is developing a platform therapy focused on hyperinflammation of vital organs. The company’s Selective Cytopheretic Device was designated as a breakthrough device by the FDA earlier this year. SeaStar is set to go public in… […]
  • Varta presents microbattery product portfolio at Computex 2022
    Varta will present its broad product portfolio of microbatteries, which make a wide range of future-proof applications possible, at Computex in Taipei starting today. Varta’s microbattery product portfolio ranges from rechargeable lithium-ion button cells to nickel metal hydride button cells, primary silver oxide cells, primary lithium button cells and cylindrical lithium batteries to hydrogen gas… […]
  • Entegris opens Life Sciences Technology Center in Massachusetts
    Entegris (Nasdaq:ENTG) announced today that it opened a new Life Sciences Technology Center in Billerica, Massachusetts. The new Life Sciences Technology Center was built to offer life sciences customers the opportunity to leverage Entegris’ cold-chain supply expertise to optimize processes, reduce costs and increase speed to market. Get the full story at our sister site,… […]
  • MedAcuity hires SVP of business development
    Medtech software development firm MedAcuity today said it has hired Simon Johnson as SVP of business development. Westford, Massachusetts-based MedAcuity said Johnson previously built the client partner team and managed strategic clients at digital consultancy Mobiquity. He also served as SVP of client services at GreenPages Technologies, responsible for driving services revenue growth leading to… […]
  • Henry Schein investors push back on executive pay
    Nearly half of Henry Schein (Nasdaq:HSIC) shareholders who voted at this month’s annual meeting voted against the company’s pay packages for top executives, according to a new SEC filing. About 48.5% of voting shareholders voted against the company’s executive pay plan in what’s known as the Say-on-Pay vote, according to vote results of the May… […]
  • Creo Medical inks collaboration agreement with Intuitive
    Creo Medical Group (LON: CREO) announced today that it has signed a multi-year collaboration agreement with Intuitive to make certain Creo surgical technologies compatible with the surgical robotic giant’s systems. The London exchange reacted by sending CREO shares up more than 4% to 100 pence apiece by the close of trading today. As of midday… […]
  • MedTrace Pharma moves forward on 15 O-water imaging tech
    MedTrace Pharma announced the first person scanned in its Rapid-Water-Flow Phase 3 clinical trial, further testing its tech to bring 15 O-water to imaging. The first subject scan took place at Aarhus University Hospital in Denmark, using 15 O-water produced, dosed and injected through MedTrace’s P3 automated delivery system. The clinical trial aims to evaluate… […]
  • Zimmer Biomet narrowly avoids shareholder rebuke on executive pay
    An unusually large share of Zimmer Biomet (NYSE:ZBH) investors voted against the orthopedics company’s pay packages for top executives at the annual shareholder meeting. About 54% of voting shareholders supported the pay packages of the company’s five top-paid executives at the May 13 meeting, according to results filed with the SEC yesterday. In 2021, nearly 93%… […]
  • BD, Mitsubishi Gas Chemical partner on better materials for plastic syringes
    BD (NYSE:BDX) announced that it partnered with Mitsubishi Gas Chemical Company on applying new technology to pre-fillable syringes. MGC develops the Oxycapt technology designed to integrate the best of plastic and glass for plastic syringes. BD and Tokyo-based MGC will work together to apply Oxycapt technology to the next generation of pre-fillable syringes (PFS) for advanced… […]

Leave a Reply